Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cardiol Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 34 | 29 | −5 |
| Shares | 6.82M | 6.35M | −476.3K (−7.0%) |
| Value | $13.1M | $10.1M | −$2.98M (−22.7%) |
New holders (7)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Robertson Stephens Wealth Management, LLC | 27,855 | $42.0K | 0.00% |
| Simplex Trading, LLC | 24,575 | $37.0K | 0.00% |
| Susquehanna International Group, LLP | 12,950 | $20.0K | 0.00% |
| CIBC World Markets Inc. | 11,210 | $17.0K | 0.00% |
| Bank of Montreal | 8,731 | $13.0K | 0.00% |
| Oliver Lagore Vanvalin Investment Group | 500 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 25 | $0 | 0.00% |
Sold out (12)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Verition Fund Management LLC | 457,732 | $847.0K |
| Two Sigma Investments, LP | 194,554 | $360.0K |
| Sabby Management, LLC | 99,440 | $184.0K |
| Renaissance Technologies LLC | 93,000 | $171.0K |
| Virtu Financial LLC | 14,812 | $27.0K |
| Brookstone Capital Management | 15,887 | $27.0K |
| Two Sigma Securities, LLC | 11,280 | $21.0K |
| Bank of America Corp | 1,300 | $2.00K |
| City State Bank | 825 | $2.00K |
| Toronto Dominion Bank | 262 | $0 |
| Cutler Group LP | 6 | $0 |
| KRS Capital Management, LLC | 100 | $0 |